The large numbers of livestock imported into GB each year pose a potential threat as animals are allowed to move freely between confluent BTV8 zones

Similar documents
COMMISSION IMPLEMENTING REGULATION (EU)

BLUETONGUE VIRUS DISEASE CONTROL STRATEGY FOR NORTHERN IRELAND

NFU INFORMATION & ANALYSIS

UK Bluetongue Control Strategy

ZOETIS ARE PROUD TO SUPPORT THE JOINT ACTION AGAINST BLUETONGUE CAMPAIGN

African swine fever in Poland- current situation and regionalization measures

Meeting of the Ministers o Agriculture and Food From South Eastern Europe in relation to Bluetongue disease

Eradication and monitoring programme for Bluetongue

EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes

Akabane Virus Risk Management in Australia. P.D. Kirkland, EMAI, Camden NSW Australia.

Welsh Government Avian Influenza - Questions & Answers

FOOT AND MOUTH DISEASE : VETERINARY RISK ASSESSMENT (VRA RD6)

Situtation of France regarding BTV 8. 8th october 2015 A. Fediaevsky, MAAAF/DGAL/SDSPA/BSA

COMMISSION REGULATION (EC) No 1266/2007 control, monitoring and surveillance of bluetongue. The EU-BTNET system. Paolo Calistri

COMMISSION REGULATION (EU)

DECISIONS. (Text with EEA relevance) (2014/199/EU)

Official Journal of the European Union

The surveillance programme for bluetongue in Norway 2014

Estimations of the Infective Period for Bluetongue in Cattle

COMMISSION REGULATION (EU) / of XXX

Workshop on Contingency planning and practical activities in surveillance on Bluetongue and FMD

(Text with EEA relevance) (2014/798/EU)

Official Journal of the European Communities COUNCIL DIRECTIVE 2001/89/EC. of 23 October 2001

General requirements of the FMD Terrestrial Animal Health Code chapter

Schmallenberg virus: Risk Management and Control Strategy in the EU

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 12 JANUARY 2016

Report of the meeting of the. Task Force on Animal Disease Surveillance. Brussels, 22 and 23 January 2009

Vaccination against Bluetongue

EUROPEAN LIVESTOCK AND MEAT TRADING UNION / EUROPÄISCHE VIEH- UND FLEISCHHANDELSUNION

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Biosecurity in pigs holdings February 2015, State Food and Veterinary Service, Lithuania

Legal basis for LSD within and outside EU Session 1: Contingency planning, risk management and communication

Bluetongue in the Federal Republic of Germany. final report. SCOFCAH, Brussels, January 2012

INITIAL EPIDEMIOLOGICAL REPORT ON THE OUTBREAK OF BLUETONGUE IN EAST ANGLIA AND SOUTH EAST ENGLAND FROM INVESTIGATIONS COMPLETED TO 19 OCTOBER 2007

Council of the European Union Brussels, 14 February 2017 (OR. en)

Self-declaration of Belgium regarding the recovery of the HPAI free status in poultry

landbouw, natuur en voedselkwaliteit Epidemiological report BTV 6 in the Netherlands

EU measures for surveillance and control of ASF in feral pigs

General requirements of the Terrestrial Code Chapter on CSF

MedInform. Ethical and healthcare considerations in relation to mandatory vaccination - Bulgarian perspective. Literature Review

HEALTH & CONSUMERS DIRECTORATE-GENERAL

Application from the Autonomous Region of the Aosta Valley to declare the territory free, pursuant to article 10 of Directive 64/432/EC, from one of

BLUETONGUE CONTROL STRATEGY, INCLUDING RECOURSE TO VACCINE

(Text with EEA relevance)

Surveillance and Schmallenberg Virus Alasdair Cook MRCVS, AHVLA. Sheep Health & Welfare Conference Worcester, 21 st November 2012

Detection of Bluetongue virus serotype 8 infection in cattle in Germany. SCoPAFF 16 January 2019

Mission of the Community Veterinary Emergency Team to Greece

ROMANIA National Sanitary Veterinary and Food Safety Authority

C 181 E/142 Official Journal of the European Communities

Lumpy skin disease situation in Bulgaria. Dramatic evolution & lessons learnt

We particularly want to highlight the following

Article Provide a general description of the husbandry and slaughtering practices in the country.

L 211/4 Official Journal of the European Union

Bovine TB: the science-policy challenges

Lumpy Skin Disease control strategy for Great Britain. [Draft 30 August 2017] Contents

PCP Stage 1 focus: To gain an understanding of the epidemiology of FMD in the country and develop a risk-based approach to reduce the impact of FMD

Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union

Self-declaration of the recovery of freedom from highly pathogenic avian influenza in poultry by the Netherlands

VACCINATION OF POULTRY AGAINST HIGHLY PATHOGENIC AVIAN INFLUENZA H5N1 (DIVA STRATEGY)

How to prevent transmission to/from domestic pigs

COUNCIL DIRECTIVE 2009/158/EC

ANIMAL HEALTH SURVEILLANCE

Overview of biosecurity systems in EU Member States. Milos Juras Food and Veterinary Office Unit F6 Animal and Welfare Grange, Dunsany (MH) - Ireland

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

OIE STANDARDS ON EVENT BASED AND ACTIVE SURVEILLANCE OF AVIAN INFLUENZA VIRUSES. Dr Gounalan Pavade OIE regional workshop, Tokyo, August 2014

VETERINARY SERVICES ACT (CAP. 437) Foot-and-Mouth Disease (Control Measures) Rules, CHAPTER I General provisions

INTERNATIONAL WORKSHOP BLUETONGUE VACCINES 19 February 2013, Strasbourg, France ABSTRACTS

OIE Terrestrial Animal Health Code RVF and trade

COMMISSION REGULATION (EC)

Risk Assessment Centre on Food Chain Project link to the Delphi priorities / EFSA Strategy topics

EPIDEMIOLOGICAL SITUATION. for S&GP, PPR andbt

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

COMMISSION DELEGATED REGULATION (EU).../... of XXX

Overview on Lumpy skin disease in the Mediterranean region: From Middle East to Europe

Controlling Foot-and-Mouth Disease in the Netherlands (21 March to 22 April 2001)

Update on the BTV situation in France. Pascal HUDELET, LA & VPH Customer Service Sept 2015

African Swine Fever only in wild boars in Belgium

FOOT AND MOUTH DISEASE DIAGNOSTICS: REQUIREMENTS FOR DEMONSTRATION OF FREEDOM FROM INFECTION

Use of a Montecarlo simulation model for the re-planning of. bluetongue surveillance in Italy

Integrating and strengthening the European research area *

Risk Analysis. Hazard identification. Dr Noel Murray 22 nd March 2018

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 05 JULY JULY 2016

HEALTH & CONSUMERS DIRECTORATE-GENERAL

Climate changes and animal infectious diseases

Introduction - Lumpy skin disease workshop

EUROPEAN COMMISSION REPORT ON THE MONITORING AND TESTING OF BOVINE ANIMALS FOR THE PRESENCE OF BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) IN 2001

The Royal Veterinary College. The Swiss Federal Veterinary Office

Belgian Food Safety Agency

Adopted by CVMP 10 March Date for coming into effect 1 July Revised draft guideline agreed by Immunologicals Working Party 22 June 2017

Planning for preparedness: EU perspectives on Avian Influenza, African Swine Fever and Lumpy Skin Disease

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a COUNCIL DIRECTIVE

Self-declaration of the recovery of country freedom from Notifiable Avian Influenza in poultry by the United Kingdom

"Schmallenberg" virus: likely epidemiological scenarios and data collection

A dynamic spatio-temporal model to investigate the effect of movements of animals on the spreading of Bluetongue BTV-8 in Belgium

Official Journal of the European Union L 8/29

African swine fever in Lithuania. SCoFcAH 21 August 2014, State Food and Veterinary Service, Lithuania

Lumpy Skin Disease Contingency Plan Template

5163/18 GSC/ar 1 DGB 2B

Regulation (EU) No 1169/ Future work on food information to consumers

Transcription:

Dear Bluetongue Stakeholders Bluetongue Update February 2010 We are currently working with Defra to consider our Bluetongue policy options 2010. Please find below a brief update of the issues under consideration. We will keep you updated as thinking develops, and would of course welcome your views. Surveillance from 2009 suggests there is no evidence of Bluetongue virus circulation last year in GB. However, the insect-born nature of bluetongue means that disease can remain for long periods and GB remains in a full protection zone for BTV8. Under EU legislation we are required to provide evidence that there has been no disease circulation for a minimum of 2 years before we are able to declare freedom from disease and remove our zones. However, EU rules only enable vaccination within a zone. We would therefore need to be reassured that disease was not likely to come back from continental Europe before we remove the zone and stop vaccinating The large numbers of livestock imported into GB each year pose a potential threat as animals are allowed to move freely between confluent BTV8 zones We are currently considering whether it would be possible and desirable to change our status to lower risk zone for BTV8. This would allow us maintain vaccinating while also putting in place additional measures to protect ourselves from the risk of importing animals which may be carrying disease. The key implications for this would be that imports into GB from other Bluetongue protection zones would need to be made under the conditions of Annex III of Council Regulation (EC) 1266/2007, unless they are moved direct to slaughter. We expect the conditions most likely to be used for moves into GB would be: vaccination plus 60 day wait vaccination plus a test 14 days after onset of immunity booster vaccination within time period of immunity However moves are also allowed if various conditions around natural immunity or vector protection are met further detail is provided at the annex to this note. We are not obliged to make any changes to our zones at this point and can remain in a full BTV8 protection zone until the point at which we apply for disease free status at some time in the future. We are currently monitoring the latest risk and science, considering the legal issues, trade implications for industry and the full range of costs and benefits, and discussing our options with the European Commission

In the next few months we will also be reviewing our post import testing regime in preparation for Spring/Summer when vectors will become more active. Livestock keepers are reminded to continue to vaccinate against BTV8 and remain vigilant for signs of disease. Please also carefully consider the risks and check the health and vaccination status of animals when sourcing susceptible animals from abroad Bluetongue Core Group

Annex III conditions - Exemptions from the Bluetongue Exit Ban If GB changes to BTV8 lower risk zone status, moves into GB from Bluetongue Protection Zones,(including BTV8 protection zones such as the Netherlands and Germany), will need to meet one of the conditions for exemption from the bluetongue exit ban, as referred to in Articles 7(2)(a) and 8(1)(a) of Commission Regulation 1266/2007, and set out in points 1 to 7 of Annex III. The animals must also have been protected against attacks by vectors during transportation to the place of destination. PROTECTION AGAINST VECTORS 1. The animals were kept until dispatch during the seasonally vector-free period defined in accordance with Annex V of 1266/2007, in a bluetongue seasonally-free zone since birth or for at least 60 days prior to the date of movement and were subjected to an agent identification test with negative results, carried out not earlier than seven days before the date of movement. The agent identification test shall not be necessary for Member States or regions of a Member State where sufficient epidemiological data, obtained following the implementation of a monitoring programme for a period of not less than three years, substantiate the determination of the seasonally vector-free period defined in accordance with Annex V of 1266/2007. 2. The animals have been kept until dispatch protected against attacks by vectors for a period of at least 60 days prior to the date of dispatch; 3. The animals have been kept until dispatch in a bluetongue seasonally-free zone during the seasonally vector-free period, defined in accordance with Annex V of 1266/2007, or have been protected against attacks by vectors for a period of at least 28 days and were subjected during that period to a serological test to detect antibodies to the bluetongue virus group, with negative results, carried out at least 28 days following the date of the commencement of the period of protection against attacks by vectors or the seasonally vector-free period; 4. The animals have been kept until dispatch in a bluetongue seasonally-free zone during the seasonally vector-free period, defined in accordance with Annex V of 1266/2007, or have been protected against attacks by vectors for a period of at least 14 days and were subjected during that period to an agent identification test, with negative results, carried out at least 14 days following the date of the commencement of the period of protection against attacks by vectors or the seasonally vector-free period; VACCINATION 5. The animals originate from a herd vaccinated according to a vaccination programme adopted by the competent authority and the animals have been vaccinated against the serotype(s) present or likely to be present in an epidemiologically relevant geographical area of origin, the animals are still within the immunity period of time guaranteed in the specifications of the vaccine

approved in the vaccination programme and the animals meet at least one of the following requirements: (a) they have been vaccinated more than 60 days before the date of movement; (b) they have been vaccinated with an inactivated vaccine before at least the number of days necessary for the onset of the immunity protection set in the specifications of the vaccine approved in the vaccination programme and were subjected to an agent identification test, with negative results, carried out at least 14 days after the onset of the immunity protection set in the specifications of the vaccine approved in the vaccination programme; (c) they were previously vaccinated and they have been re-vaccinated with an inactivated vaccine within the immunity period of time guaranteed in the specifications of the vaccine approved in the vaccination programme; (d) they were kept during the seasonally vector-free period, defined in accordance with Annex V, in a bluetongue seasonally-free zone, since birth or for a period of at least 60 days before the date of vaccination and have been vaccinated with an inactivated vaccine before at least the number of days necessary for the onset of the immunity protection set in the specifications of the vaccine approved in the vaccination programme. NATURAL IMMUNITY 6. The animals have never been vaccinated against bluetongue and were always kept in an epidemiologically relevant geographical area of origin where not more than one serotype was or is present or likely to be present and: (a) they were subjected to two serological tests to detect antibodies against the bluetongue virus serotype, with positive results; the first test must be carried out on samples taken between 60 and 360 days before the date of movement and the second test being carried out on samples taken not earlier than seven days before the date of the movement; or (b) they were subjected to a serological test according to detect antibodies against the bluetongue virus serotype, with positive results; the test must be carried out at least 30 days before the date of the movement and the animals were subjected to an agent identification test, with negative results, carried out not earlier than seven days before date of the movement. 7. The animals have never been vaccinated against the bluetongue virus and were subjected with positive results to two adequate serological tests able to detect the specific antibodies against all the bluetongue virus serotypes present or likely to be present, in the epidemiologically relevant geographical area of origin, and:

(a) the first test must have been carried out on samples that were taken between 60 and 360 days before the date of movement and the second test must have been carried out on samples that were taken not earlier than seven days before the date of movement; or (b) the specific serotype serological test must have been carried out at least 30 days before the date of the movement and the animals were subjected to an agent identification test with negative results, carried out not earlier than seven days before the date of movement. PREGNANT ANIMALS For pregnant animals, at least one of the conditions set out in points 5, 6 and 7 must be complied with before insemination or mating, or the condition set out in point 3 must be complied with. In case a serological test, as set out in point 3, is carried out, that test shall be carried out not earlier than seven days before the date of movement. A copy of the Bluetongue Regulations can be found at the following link http://eurlex.europa.eu/lexuriserv/lexuriserv.do?uri=consleg:2007r1266:20090 214:EN:PDF